Items where authors include "Del Galdo, F."

Article

Chandler, F., Narayana Reddy, P.A., Bhutda, S. et al. (21 more authors) (2025) Molecular glues that inhibit deubiquitylase activity and inflammatory signalling. Nature Structural & Molecular Biology. ISSN 1545-9993 (In Press)

Di Donato, S. orcid.org/0000-0003-1256-0761, Ross, R., Karanth, R. et al. (7 more authors) (2025) Serum Type I Interferon Score predicts clinically meaningful disease progression in limited cutaneous Systemic Sclerosis. Arthritis & Rheumatology. ISSN 2326-5191

Bjørkekjær, H.J., Bruni, C., Broch, K. et al. (60 more authors) (2025) A comparative analysis of risk stratification tools in SSc-associated pulmonary arterial hypertension: a EUSTAR analysis. Rheumatology. keaf053. ISSN 1462-0324

Roth, E., Bruni, C., Petelytska, L. et al. (244 more authors) (2025) Gastroesophageal reflux disease is associated with a more severe interstitial lung disease in systemic sclerosis in the EUSTAR cohort. Rheumatology. keaf016. ISSN 1462-0324

Del Galdo, F. orcid.org/0000-0002-8528-2283, Lescoat, A., Conaghan, P.G. orcid.org/0000-0002-3478-5665 et al. (23 more authors) (2025) EULAR recommendations for the treatment of systemic sclerosis: 2023 update. Annals of the Rheumatic Diseases, 84 (1). pp. 29-40. ISSN 0003-4967

Ross, R.L., Caballero-Ruiz, B., Clarke, E.L. et al. (11 more authors) (2024) Biological hallmarks of systemic sclerosis are present in the skin and serum of patients with Very Early Diagnosis of SSc (VEDOSS). Rheumatology. keae698. ISSN 1462-0324

Mongin, D., Matucci‐Cerinic, M., Walker, U.A. et al. (16 more authors) (2024) Oral glucocorticoids for skin fibrosis in early diffuse systemic sclerosis: a target trial emulation study from the European Scleroderma Trials and Research group database. Arthritis Care & Research. ISSN 2151-464X

Topping, J., Chang, L., Nadat, F. et al. (17 more authors) (2024) Characterization of genetic landscape and novel inflammatory biomarkers in patients with adult-onset Still's disease. Arthritis & Rheumatology. ISSN 2326-5191

Feher, A., Del Galdo, F. orcid.org/0000-0002-8528-2283 and Plein, S. orcid.org/0000-0002-0997-4384 (2024) Advances in the diagnosis of multiorgan involvement in systemic sclerosis: a focus on MRI. Current Opinion in Rheumatology, 36 (6). pp. 387-392. ISSN 1040-8711

Wyss, A., Jordan, S., Graf, N. et al. (18 more authors) (2024) Does regression of skin thickening predict improvement of internal organ involvement and survival in patients with diffuse cutaneous systemic sclerosis? A EUSTAR analysis. Arthritis Research & Therapy, 26. 187. ISSN 1478-6354

Bryon, J., Wasson, C.W. orcid.org/0000-0001-6558-4738, Koeppen, K. et al. (7 more authors) (2024) Systemic Sclerosis dermal fibroblast exosomes trigger a Type 1 interferon response in keratinocytes through the TBK/JAK/STAT signalling axis. Arthritis & Rheumatology. ISSN 2326-5191

Spierings, J., Welsing, P.M.J., Colak, S. et al. (7 more authors) (2024) Self-reported skin severity and quality of life in systemic sclerosis: multicentre validation of PASTUL. Rheumatology. keae561. ISSN 1462-0324

Mills, T.J., Price, E., Aggarwal, V.R. orcid.org/0000-0003-0838-9682 et al. (2 more authors) (2024) Oral health and dental care challenges in scleroderma - perspectives of dentists, rheumatologists, and patients. Rheumatology Advances in Practice, 8 (4). rkae121. ISSN 2514-1775

Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X, Del Galdo, F. orcid.org/0000-0002-8528-2283 and Marzo-Ortega, H. (2024) Clinical hypnosis and pain management in sharp debridement of skin ulcers in immune-mediated inflammatory diseases. The Lancet Rheumatology, 6 (10). e664-e665. ISSN 2665-9913

Di Donato, S., Huang, S., Pauling, J.D. et al. (4 more authors) (2024) Clinically relevant differences between primary Raynaud's phenomenon and secondary to connective tissue disease. Seminars in Arthritis and Rheumatism, 68. 152521. ISSN 0049-0172

Colalillo, A., Hachulla, E., Pellicano, C. et al. (35 more authors) (2024) Diffusing Capacity of the Lungs for Carbon Monoxide and Echocardiographic Parameters in Identifying Mild Pulmonary Hypertension in the EUSTAR Cohort of Patients With Systemic Sclerosis. Chest Journal, 166 (4). pp. 837-844. ISSN 0012-3692

Wasson, C.W., De Lorenzis, E., Clavane, E.M. et al. (14 more authors) (2024) The β-Secretase BACE1 Drives Fibroblast Activation in Systemic Sclerosis through the APP/β-Catenin/Notch Signaling Axis. Journal of Investigative Dermatology, 144 (10). pp. 2197-2210. ISSN 0022-202X

Sgrò, P., Antinozzi, C., Wasson, C.W. et al. (3 more authors) (2024) Sexual Dimorphism in Sex Hormone Metabolism in Human Skeletal Muscle Cells in Response to Different Testosterone Exposure. Biology, 13 (10). 796. ISSN 2079-7737

Suresh, N. orcid.org/0000-0001-7431-3921, Karanth, R., Cheah, R. et al. (3 more authors) (2024) Systemic sclerosis and anorectal dysfunction: The Leeds experience. Journal of Scleroderma and Related Disorders, 9 (3). 210 -215. ISSN 2397-1983

De Lorenzis, E., Natalello, G., Pellegrino, G. et al. (29 more authors) (2024) Long-term retention rate, adverse event temporal patterns and rescue treatment strategies of mycophenolate mofetil in systemic sclerosis: insights from real-life. Rheumatology. keae532. ISSN 1462-0324

Denton, C.P., De Lorenzis, E., Roblin, E. et al. (27 more authors) (2024) The 2024 British Society for Rheumatology guideline for management of systemic sclerosis. Rheumatology. keae394. ISSN 1462-0324

Denton, C.P., De Lorenzis, E., Roblin, E. et al. (27 more authors) (2024) The 2024 British Society for Rheumatology guideline for management of systemic sclerosis—executive summary. Rheumatology. keae390. ISSN 1462-0324

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Mor, A., Ross, R.L. et al. (4 more authors) (2024) Serum CCL24 as a biomarker of fibrotic and vascular disease severity in Systemic Sclerosis. Arthritis Care & Research, 76 (9). pp. 1269-1277. ISSN 2151-464X

McMahan, Z., Pandolfino, J., Perlman, H. et al. (2 more authors) (2024) Gastrointestinal disease in systemic sclerosis: the neglected organ system? Current Opinion in Rheumatology, 36. ISSN 1040-8711

Khanna, D., Denton, C.P., Assassi, S. et al. (12 more authors) (2024) A randomised, parallel-group, double-blind, placebo-controlled phase 3 study to Determine the effectiveness of the type I interferon receptor antibody, Anifrolumab, In SYstemic sclerosis: DAISY study design and rationale. Clinical and Experimental Rheumatology, 42 (8). pp. 1635-1644. ISSN 0392-856X

Coccia, C., Bonomi, F., Cricchio, A.L. et al. (11 more authors) (2024) The Potential Role of Butyrate in the Pathogenesis and Treatment of Autoimmune Rheumatic Diseases. Biomedicines, 12 (8). 1760. ISSN 2227-9059

De Lorenzis, E., Del Galdo, F., Natalello, G. et al. (10 more authors) (2024) Concordance and Prognostic Relevance of Different Definitions of Systemic Sclerosis Interstitial Lung Disease Progression. American Journal of Respiratory and Critical Care Medicine. ISSN 1073-449X

Ruscitti, P., Allanore, Y., Baldini, C. et al. (70 more authors) (2024) Tailoring the treatment of inflammatory rheumatic diseases by a better stratification and characterization of the clinical patient heterogeneity. Findings from a systematic literature review and experts' consensus. Autoimmunity Reviews, 23 (7-8). 103581. ISSN 1568-9972

Velauthapillai, A., Bootsma, M.F.R., Bruni, C. et al. (118 more authors) (2024) Preventive effects of early immunosuppressive treatment on the development of interstitial lung disease in systemic sclerosis. Rheumatology. keae375. ISSN 1462-0324

Avanoglu-Guler, A. orcid.org/0000-0001-9866-9797, Campochiaro, C., De Luca, G. et al. (6 more authors) (2024) Calcinosis in systemic sclerosis: An update on pathogenesis, related complications, and management: A heavy burden still waiting to be lifted off patients’ hands. Seminars in Arthritis and Rheumatism, 66. 152431. ISSN 0049-0172

Mills, T.J., Price, E., Aggarwal, V.R. orcid.org/0000-0003-0838-9682 et al. (2 more authors) (2024) Clinician and Patient Experiences of Managing and Living with Oral and Dental Manifestations of Scleroderma: A Scoping Review. Journal of Scleroderma and Related Disorders, 9 (2). 86 -98. ISSN 2397-1983

Wasson, C., Dibb, S., Bryon, J. et al. (8 more authors) (2024) P27 Chloride intracellular channel 4 is a global regulator of type 1 interferon signalling in systemic sclerosis skin. British Journal of Dermatology, 190 (6). e91-e92. ISSN 0007-0963

Lee, P., Green, L., Marzec, B. et al. (3 more authors) (2024) Dystrophic calcinosis: structural and morphological composition, and evaluation of ethylenediaminetetraacetic acid (‘EDTA’) for potential local treatment. Arthritis Research and Therapy, 26. 102. ISSN 1478-6354

Álvarez-Hernández, M.P. orcid.org/0000-0002-9972-1312, Allanore, Y., Andrade, I. et al. (9 more authors) (2024) Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: A survey of UK-based rheumatologists. Journal of Scleroderma and Related Disorders. ISSN 2397-1983

Bandini, G. orcid.org/0000-0002-2076-7319, Alunno, A. orcid.org/0000-0003-1105-5640, Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X et al. (14 more authors) (2024) Patients’ unmet needs and treatment preferences concerning digital ulcers in systemic sclerosis. Rheumatology. keae130. ISSN 1462-0324

Tornling, G., Edenius, C., Pauling, J.D. et al. (16 more authors) (2024) A phase 2 trial investigating the efficacy and safety of the mPGES-1 inhibitor vipoglanstat in systemic sclerosis-related Raynaud's. Rheumatology. keae049. ISSN 1462-0324

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Kakkar, V., Di Donato, S. et al. (13 more authors) (2024) Clinical trajectories of hand function impairment in systemic sclerosis: an unmet clinical need across disease subsets. RMD Open, 10 (1). e003216. ISSN 2056-5933

Liakouli, V. orcid.org/0000-0002-7392-9334, Ciancio, A., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (2 more authors) (2024) Systemic sclerosis interstitial lung disease: unmet needs and potential solutions. Nature Reviews Rheumatology, 20 (1). pp. 21-32. ISSN 1759-4790

Lepri, G., Bruni, C. orcid.org/0000-0003-2813-2083, Tofani, L. orcid.org/0000-0001-9965-7667 et al. (23 more authors) (2024) The Performance of Pulmonary Function Tests in Predicting Systemic Sclerosis—Interstitial Lung Disease in the European Scleroderma Trial and Research Database. Diagnostics, 14 (3). ARTN 295. ISSN 2075-4418

Lescoat, A., Bellando-Randone, S., Campochiaro, C. et al. (9 more authors) (2023) Beyond very early systemic sclerosis: deciphering pre‑scleroderma and its trajectories to open new avenues for preventive medicine. The Lancet Rheumatology, 5 (11). e683-e694. ISSN 2665-9913

Di Battista, M. orcid.org/0000-0002-4788-5729, Wasson, C.W., Alcacer-Pitarch, B. orcid.org/0000-0002-2208-444X et al. (1 more author) (2023) Autonomic dysfunction in systemic sclerosis: A scoping review. Seminars in Arthritis and Rheumatism, 63. 152268. ISSN 0049-0172

Hughes, M. orcid.org/0000-0003-3361-4909, Di Donato, S. orcid.org/0000-0003-1256-0761, Gjeloshi, K. et al. (9 more authors) (2023) MRI Digital Artery Volume Index (DAVIX) as a surrogate outcome measure of digital ulcer disease in patients with systemic sclerosis: a prospective cohort study. The Lancet Rheumatology, 5 (10). e611-e621. ISSN 2665-9913

De Lorenzis, E., Rindone, A., Di Donato, S. et al. (1 more author) (2023) Circulating extracellular vesicles in the context of interstitial lung disease related to systemic sclerosis: A scoping literature review. Autoimmunity Reviews, 22 (9). 103401. ISSN 1568-9972

Griffiths-Jones, D.J., Garcia, Y.S., Ryder, W.D. et al. (19 more authors) (2023) A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS). Rheumatology, 62 (9). pp. 3133-3138. ISSN 1462-0324

Griffiths-Jones, D.J., Garcia, Y.S., Ryder, W.D. et al. (19 more authors) (2023) A Phase II randomized controlled trial of oral prednisolone in early diffuse cutaneous systemic sclerosis (PRedSS). Rheumatology, 62 (9). pp. 3133-3138. ISSN 1462-0324

Colalillo, A., Pellicano, C., Ananyeva, L.P. et al. (12 more authors) (2023) Tricuspid Annular Plane Systolic Excursion/Systolic Pulmonary Artery Pressure Ratio and Cardiorenal Syndrome Type 2 in the Systemic Sclerosis EUSTAR Cohort. Arthritis Care & Research. ISSN 2151-464X

Lescoat, A., Huang, S., Carreira, P.E. et al. (219 more authors) (2023) Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients With Systemic Sclerosis Sine Scleroderma: Data From the International EUSTAR Database. JAMA Dermatology, 159 (8). pp. 837-847. ISSN 2168-6068

Lepri, G., Hughes, M., Allanore, Y. et al. (8 more authors) (2023) The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution. The Lancet Rheumatology, 5 (7). e422-e425. ISSN 2665-9913

De Lorenzis, E. orcid.org/0000-0001-9819-105X, Wasson, C.W. and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2023) Alveolar epithelial-to-mesenchymal transition in scleroderma interstitial lung disease: Technical challenges, available evidence and therapeutic perspectives. Journal of Scleroderma and Related Disorders. ISSN 2397-1983

John, A.J.U.K. orcid.org/0000-0003-3080-7393, Del Galdo, F. orcid.org/0000-0002-8528-2283, Gush, R. orcid.org/0000-0002-8624-3606 et al. (1 more author) (2023) An evaluation of mechanical and biophysical skin parameters at different body locations. Skin Research and Technology, 29 (2). e13292. ISSN 0909-752X

Dumitru, R.B., Bissell, L., Erhayiem, B. et al. (8 more authors) (2023) Subclinical Systemic Sclerosis Primary Heart Involvement by Cardiovascular Magnetic Resonance Shows No Significant Interval Change. ACR Open Rheumatology, 5 (2). pp. 71-80. ISSN 2578-5745

Hughes, M., Huang, S., Alegre-Sancho, J.J. et al. (98 more authors) (2023) Late skin fibrosis in systemic sclerosis: a study from the EUSTAR cohort. Rheumatology, 62 (SI). SI54-SI63. ISSN 1462-0324

Garaiman, A., Steigmiller, K., Gebhard, C. et al. (171 more authors) (2023) Use of platelet inhibitors for digital ulcers related to systemic sclerosis: EUSTAR study on derivation and validation of the DU-VASC model. Rheumatology, 62 (SI). SI91-SI100. ISSN 1462-0324

Bosello, S.L., Vital, E.M. orcid.org/0000-0003-1637-4755 and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2022) More to B: the growing evidence to inform targeting B cells in scleroderma. Rheumatology, 62 (5). pp. 1730-1732. ISSN 1462-0324

Kuster, S., Jordan, S., Elhai, M. et al. (104 more authors) (2022) Effectiveness and safety of tocilizumab in patients with systemic sclerosis: a propensity score matched controlled observational study of the EUSTAR cohort. RMD Open, 8 (2). e002477. ISSN 2056-5933

Campochiaro, C. orcid.org/0000-0001-6806-3794, Hoffmann-Vold, A.-M. orcid.org/0000-0001-6467-7422, Avouac, J. et al. (90 more authors) (2022) Sex influence on outcomes of patients with systemic sclerosis–associated interstitial lung disease: a EUSTAR database analysis. Rheumatology, 62 (7). pp. 2483-2491. ISSN 1462-0324

Bellando-Randone, S., Del Galdo, F. orcid.org/0000-0002-8528-2283 and Matucci-Cerinic, M. (2022) Insights into molecular and clinical characteristics of very early systemic sclerosis. Current Opinion in Rheumatology, 34 (6). pp. 351-356. ISSN 1040-8711

Kakkar, V., Assassi, S., Allanore, Y. et al. (4 more authors) (2022) Type 1 interferon activation in systemic sclerosis: a biomarker, a target or the culprit. Current Opinion in Rheumatology, 34 (6). pp. 357-364. ISSN 1040-8711

Hughes, M., Allanore, Y., Baron, M. et al. (13 more authors) (2022) Proton pump inhibitors in systemic sclerosis: a reappraisal to optimise treatment of gastro-oesophageal reflux disease. The Lancet Rheumatology, 4 (11). e795-e803. ISSN 2665-9913

Elhai, M., Sritharan, N., Boubaya, M. et al. (167 more authors) (2022) Stratification in systemic sclerosis according to autoantibody status versus skin involvement: a study of the prospective EUSTAR cohort. The Lancet Rheumatology, 4 (11). e785-e794. ISSN 2665-9913

Kondo, M., Suzuki, T., Kawano, Y. et al. (10 more authors) (2022) Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis. Arthritis Research & Therapy, 24. 210. ISSN 0003-4967

Cipriani, P., Ruscitti, P., Di Cola, I. et al. (6 more authors) (2022) Fibroblast expression of CD248 may contribute to exacerbation of microvascular damage during systemic sclerosis. Rheumatology, 62 (3). pp. 1317-1325. ISSN 1462-0324

Zheng, B. orcid.org/0000-0003-2509-5766, Wang, M., McKenna, K. et al. (16 more authors) (2022) Agreement Between Physician Evaluation and the Composite Response Index in Diffuse Cutaneous Systemic Sclerosis. Arthritis Care & Research, 74 (11). pp. 1806-1812. ISSN 2151-464X

Abignano, G. orcid.org/0000-0002-1479-0133, Green, L. orcid.org/0000-0003-1620-2443, Eng, S. et al. (2 more authors) (2022) Nailfold Microvascular Imaging by Dynamic Optical Coherence Tomography in Systemic Sclerosis: A Case-Controlled Pilot Study. Journal of Investigative Dermatology, 142 (4). pp. 1050-1057. ISSN 0022-202X

Lescoat, A., Murphy, S.L., Chen, Y.T. et al. (5 more authors) (2022) Symptom experience of limited cutaneous systemic sclerosis from the Patients’ perspective: A qualitative study. Seminars in Arthritis and Rheumatism, 52. 151926. ISSN 0049-0172

Kreuter, M. orcid.org/0000-0003-4402-2159, Del Galdo, F. orcid.org/0000-0002-8528-2283, Miede, C. et al. (7 more authors) (2022) Impact of lung function decline on time to hospitalisation events in systemic sclerosis-associated interstitial lung disease (SSc-ILD): a joint model analysis. Arthritis Research & Therapy, 24. 19. ISSN 1478-6354

Lazzaroni, M-G., Marasco, E., Campochiaro, C. et al. (30 more authors) (2021) The clinical phenotype of systemic sclerosis patients with anti-PM/Scl antibodies: results from the EUSTAR cohort. Rheumatology, 60 (11). pp. 5028-5041. ISSN 1462-0324

Abignano, G. orcid.org/0000-0002-1479-0133, Hermes, H., Piera-Velazquez, S. et al. (3 more authors) (2021) Global gene expression analysis of systemic sclerosis myofibroblasts demonstrates a marked increase in the expression of multiple NBPF genes. Scientific Reports, 11. 20435. ISSN 2045-2322

Abignano, G. orcid.org/0000-0002-1479-0133, Mennillo, G.A., Lettieri, G. orcid.org/0000-0002-7422-554X et al. (6 more authors) (2021) UCLA Scleroderma Clinical Trials Consortium Gastrointestinal Tract (GIT) 2.0 Reflux Scale Correlates With Impaired Esophageal Scintigraphy Findings in Systemic Sclerosis. The Journal of Rheumatology, 48 (9). pp. 1422-1426. ISSN 0315-162X

Di Battista, M., Barsotti, S., Orlandi, M. et al. (5 more authors) (2021) One year in review 2021: systemic sclerosis. Clinical and Experimental Rheumatology, 39 (4). S3-S12. ISSN 0392-856X

Suliman, Y., Kafaja, S., Oh, S.J. et al. (12 more authors) (2021) Anti-vinculin antibodies in scleroderma (SSc): a potential link between autoimmunity and gastrointestinal system involvement in two SSc cohorts. Clinical Rheumatology, 40 (6). pp. 2277-2284. ISSN 0770-3198

Antinozzi, C. orcid.org/0000-0003-4296-5081, Sgrò, P. orcid.org/0000-0003-4929-2764, Marampon, F. et al. (4 more authors) (2021) Sildenafil Counteracts the In Vitro Activation of CXCL-9, CXCL-10 and CXCL-11/CXCR3 Axis Induced by Reactive Oxygen Species in Scleroderma Fibroblasts. Biology, 10 (6). 491. ISSN 2079-7737

Corinaldesi, C., Ross, R.L., Abignano, G. orcid.org/0000-0002-1479-0133 et al. (8 more authors) (2021) Muscle Damage in Systemic Sclerosis and CXCL10: The Potential Therapeutic Role of PDE5 Inhibition. International Journal of Molecular Sciences, 22 (6). 2894. ISSN 1661-6596

Hoffmann-Vold, A.-M., Allanore, Y., Alves, M. et al. (87 more authors) (2021) Progressive interstitial lung disease in patients with systemic sclerosis-associated interstitial lung disease in the EUSTAR database. Annals of the Rheumatic Diseases, 80 (2). pp. 219-227. ISSN 0003-4967

Wasson, C., Ross, R., Wells, R. et al. (4 more authors) (2020) Long Non-coding RNA HOTAIR Induces GLI2 Expression Through Notch Signalling in Systemic Sclerosis Dermal Fibroblasts. Arthritis Research & Therapy, 22. 286. ISSN 1478-6354

Lescoat, A., Murphy, S.L., Roofeh, D. et al. (17 more authors) (2020) Considerations for a combined index for limited cutaneous systemic sclerosis to support drug development and improve outcomes. Journal of Scleroderma and Related Disorders, 6 (1). 66 -76. ISSN 2397-1983

Abignano, G. orcid.org/0000-0002-1479-0133 and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2020) Biomarkers as an opportunity to stratify for outcome in systemic sclerosis. European Journal of Rheumatology, 7 (Supplement 3). S193-S202. ISSN 2147-9720

Di Luigi, L., Duranti, G., Antonioni, A. et al. (9 more authors) (2020) The Phosphodiesterase Type 5 Inhibitor Sildenafil Improves DNA Stability and Redox Homeostasis in Systemic Sclerosis Fibroblasts Exposed to Reactive Oxygen Species. Antioxidants, 9 (9). 786. ISSN 2076-3921

Del Galdo, F. orcid.org/0000-0002-8528-2283, Hartley, C. and Allanore, Y. (2020) Randomised controlled trials in systemic sclerosis: patient selection and endpoints for next generation trials. The Lancet Rheumatology, 2 (3). e173-e184. ISSN 2665-9913

Conference or Workshop Item

DI Donato, S., Ross, R., Karanth, R. et al. (6 more authors) (2024) OP0314 Interferon score as a novel trial enrichment tool to predict clinical outcomes in patients with limited cutaneous systemic sclerosis. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Roth, E., Bruni, C., Petelytska, L. et al. (18 more authors) (2024) POS0230 Characteristics and disease course of SSc-ILD patients with gastroesophageal reflux – an analysis of the EUSTAR cohort. In: EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria.

Álvarez Hernández, M. P., Allanore, Y., Andrade, I. et al. (9 more authors) (2024) E061 Attitudes and barriers to pulmonary arterial hypertension screening in systemic sclerosis patients: a survey of UK-based rheumatologists. In: British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool.

Spierings, J., Ong, V.H., Welsing, P.M.J. et al. (5 more authors) (2024) P139 Self-assessment of scleroderma skin: validation of the PASTUL questionnaire. In: British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool.

Del Galdo, F. orcid.org/0000-0002-8528-2283, Tian, Y., Di Donato, S. et al. (1 more author) (2023) The Patient Journey to a First Diagnosis of Systemic Sclerosis: Temporal Disease Pattern Identification Using Machine Learning and Data Mining Among US and Japanese Patients. In: ACR Convergence 2023, 10-15 Nov 2023, San Diego, California.

Del Galdo, F. orcid.org/0000-0002-8528-2283, Khanna, D., Crater, C. et al. (6 more authors) (2023) AB0808 a proof of biological concept trial of CM101 to target CCL24 in systemic sclerosis: a biomarker informed, precision medicine approach. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

De Lorenzis, E., Natalello, G., Di Donato, S. et al. (6 more authors) (2023) AB0841 concordance and prognostic relevance of different definitions of systemic sclerosis interstitial lung disease progression. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (13 more authors) (2023) AB0881 clinical trajectories of multifactorial hand function deterioration in systemic sclerosis. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Ross, R., Clarke, E., Merchant, W. et al. (8 more authors) (2023) POS0146 biosamples from vedoss patients show classic pathological signs of scleroderma:opportunity for a biological diagnosis of disease. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Verardi, L., De Lorenzis, E., Pellegrino, G. et al. (19 more authors) (2023) POS1324 mycophenolate mofetil use in clinical practice in a multicentric cohort of scleroderma patients: persistence on therapy and long-term adverse events. In: EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy.

Stock, C., Kreuter, M., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (7 more authors) (2021) PRS3 Joint Modelling of Forced Vital Capacity Decline and Time to Hospitalization Outcomes in Systemic Sclerosis-Associated Interstitial Lung Disease. In: Virtual ISPOR 2021, 17-20 May 2021, Online.

Temiz Karadağ, D., Gundogdu, O., Lettieri, G. et al. (5 more authors) (2020) AB0617 optical coherence tomography in the assessment of skin fibrosis in systemic sclerosis: a cross-sectional study. In: EULAR 2020 - Annual European Congress of Rheumatology, 03-06 Jun 2020, Virtual.

Abignano, G. orcid.org/0000-0002-1479-0133, Temiz Karadağ, D., Gundogdu, O. et al. (6 more authors) (2020) FRI0226 optical coherence tomography of the skin detects scleroderma changes in clinically unaffected skin: an opportunity for early detection of systemic sclerosis. In: EULAR 2020 - Annual European Congress of Rheumatology, 03-06 Jun 2020, Virtual.

Abignano, G., Karadag, D.T., Gundogdu, O. et al. (6 more authors) (2020) P161 Optical coherence tomography of the skin detects scleroderma changes in clinically unaffected skin: an opportunity for early detection of systemic sclerosis. In: British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow (Event Cancelled).

Proceedings Paper

Chang, L., Topping, J., Nadat, F. et al. (13 more authors) (2024) OP0006 CHARACTERISATION OF GENETIC LANDSCAPE AND NOVEL INFLAMMATORY BIOMARKERS IDENTIFIES NOVEL TREATMENT TARGETS IN ADULT-ONSET STILL’S DISEASE. In: Annals of the Rheumatic Diseases. EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria. BMJ , pp. 200-201.

Mongin, D., Matucci-Cerinic, M., Walker, U. et al. (15 more authors) (2024) POS0832 Immunosuppression Versus Combination Of Immunosuppression And Oral Glucocorticoids For Skin Fibrosis In Early Diffuse Systemic Sclerosis Patients. A Target Trial Emulation Study From The Eustar Database. In: Annals of the Rheumatic Diseases. EULAR 2024 European Congress of Rheumatology, 12-15 Jun 2024, Vienna, Austria. BMJ Publishing Group .

Shukla, R., Dumitru, R.B., Erhayiem, B. et al. (5 more authors) (2024) P143 High throughput multiplex assay identifies clinically meaningful clusters in systemic sclerosis patients with low cardiovascular risk and no history of heart disease. In: Rheumatology. British Society for Rheumatology Annual Conference 2024, 24-26 Apr 2024, Liverpool, United Kingdom. Oxford University Press .

Wasson, C., Clavane, E., Ross, R. et al. (7 more authors) (2023) OP0113 The Beta Secretase Bace1 Drives Systemic Sclerosis Fibroblasts Activation Through Β-Catenin And Notch Signalling. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 75.

Del Galdo, F. orcid.org/0000-0002-8528-2283, Lescoat, A., Conaghan, P.G. et al. (24 more authors) (2023) OP0234 2023 Update Of Eular Recommendations For The Treatment Of Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 154-155.

Bruni, C., Tofani, L., Fretheim, H. et al. (55 more authors) (2023) OP0238 Immunosuppression With Targeted Dmards Reduces Morbidity And Mortality In Pre-Capillary Pulmonary Hypertension Associated With Systemic Sclerosis: A Eustar Analysis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 157-159.

Klotsche, J., Foeldvari, I., Torok, K. et al. (37 more authors) (2023) POS0141 Application Of Criss Score, Revised Criss Score And RCID Score In Patients With Juvenile Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 290-291.

Del Galdo, F. orcid.org/0000-0002-8528-2283, Bissell, L.A., Huang, S. et al. (4 more authors) (2023) POS0338 Development And Validation Of Ranked Composite Important Difference (RCID) Score In Diffuse Cutaneous Systemic Sclerosis. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 416.

Cheung, W.C., Shukla, R., Dumitru, R. et al. (8 more authors) (2023) POS0627 Blood-Based Protein Biomarkers Are Associated With Subclinical Cardiovascular Abnormalities As Defined By Cardiovascular Magnetic Resonance Imaging In Systemic Sclerosis (Ssc) Patients. In: Annals of the Rheumatic Diseases (ARD). EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 587-588.

De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 971.

Hughes, M., Di Donato, S., Gjeloshi, K. et al. (9 more authors) (2023) MRI digital artery volume index (DAVIX©) as quantitative, continuous imaging outcome measure of vascular disease in systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 1018.

Lescoat, A., Chen, Y., Murphy, S.L. et al. (22 more authors) (2023) POS1258 Results from a nominal group technique exercise for the creation of a combined response index for limited cutaneous systemic sclerosis: The CRISTAL project. In: Annals of the Rheumatic Diseases. EULAR 2023 - European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 971-972.

Hensor, E., Lazzaroni, M.G., Wilson, M. et al. (2 more authors) (2023) Pitfalls when estimating causal effects in observational data: a simulation study based on the eustar database. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , pp. 991-992.

Lescoat, A., Bertoldo, E., Colic, J. et al. (6 more authors) (2023) Systematic literature review for the 2023 update of eular recommendations for the treatment of systemic sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2023 European Congress of Rheumatology, 31 May - 03 Jun 2023, Milan, Italy. BMJ Publishing Group , p. 973.

Teenan, O., Kenaan, A., Del Galdo, F. orcid.org/0000-0002-8528-2283 et al. (2 more authors) (2023) 1577 MicroRNA biomarkers in interstitial skin fluid for preclinical diagnosis of scleroderma. In: Journal of Investigative Dermatology. 1st International Societies for Investigative Dermatology Meeting (ISID 2023), 10-13 May 2023, Tokyo, Japan. Elsevier , S270.

Di Donato, S., Hughes, M., Geloshi, K. et al. (6 more authors) (2023) P156 Evidence of Type I interferon activation during vascular manifestations of systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E., Kakkar, V., Di Donato, S. et al. (4 more authors) (2023) P159 Clinical trajectories and predictors of hand function deterioration in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Ross, R.L., Clarke, E., Merchant, W. et al. (8 more authors) (2023) P162 Biosamples from VEDOSS patients show classic pathological signs of Scleroderma: Opportunity for a biological diagnosis of disease. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 2023-04-24 2023-04-26, Manchester, UK. Oxford University Press .

Bryon, J.A., Wasson, C., Ross, R.L. et al. (2 more authors) (2023) Systemic Sclerosis Dermal Fibroblast-derived Exosomes trigger a Type I Interferon Response in Keratinocytes, through Tank Binding Kinase 1. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

De Lorenzis, E., Mor, A., Ross, R. et al. (5 more authors) (2023) OA28 CCL24 serum concentration predicts both vascular and fibrotic complications in systemic sclerosis: rationale for a biological target driven basket trial across disease subsets. In: Rheumatology. British Society for Rheumatology Annual Conference 2023, 24-26 Apr 2023, Manchester, UK. Oxford University Press .

Lazzaroni, M.G., Wilson, M., Hensor, E. orcid.org/0000-0002-5245-4755 et al. (15 more authors) (2022) POS0893 Factors to consider for measuring the effect of lung function on patient reported outcomes in Systemic Sclerosis patients: Analysis of the EUSTAR database. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 743-744.

Segal Salto, M., Mor, A. and Del Galdo, F. orcid.org/0000-0002-8528-2283 (2022) POS0489 CCL24 Serum Concentration Correlates With Disease Activity And Worse Prognosis In Diffuse Cutaneous Ssc: A Promising Biological Target To Prevent Disease Progression. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , 499.1-49499.

De Lorenzis, E., Kakkar, V., Ross, R. et al. (11 more authors) (2022) POS0876 Serum Interferon Score Predicts Severity Of Patient Reported Hand Disability In Systemic Sclerosis. In: Annals of the Rheumatic Diseases. EULAR 2022 European Congress of Rheumatology, 01-04 Jun 2022, Copenhagen, Denmark. BMJ , pp. 733-734.

Dumitru, R.B., Goodall, A., Broadbent, D. et al. (6 more authors) (2020) FRI0236 First pilot study of T1 mapping MRI with ECV measurement of peripheral muscle in systemic sclerosis patients shows diffuse fibrosis. In: Annals of the Rheumatic Diseases. EULAR 2020 - European E-Congress of Rheumatology, 03-06 Jun 2020, Online. BMJ , p. 702.

Wasson, C.W., Abignano, G. orcid.org/0000-0002-1479-0133, Ross, R. et al. (1 more author) (2020) O30 Long non-coding RNA HOTAIR induces beta catenin expression in systemic sclerosis through EZH2 dependent repression of Axin-2. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press , ii14.

Karadag, D.T., Lettieri, G., Picerno, V. et al. (7 more authors) (2020) P162 Cross-validation and complementary value of optical coherence tomography and high frequency ultrasound for the assessment of skin disease in systemic sclerosis. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press , ii78.

Ross, R.L., Georgiou, I., Carriero, A. et al. (6 more authors) (2020) P163 Biosamples from at risk SSc patients show classic pathological signs of scleroderma: opportunity for a diagnosis of pre-clinical SSc. In: Rheumatology. British Society for Rheumatology Annual Conference 2020, 20-22 Apr 2020, Glasgow, UK. Oxford University Press .

Preprint

Chandler, F., Reddy, P.A.N., Bhutda, S. et al. (20 more authors) (2024) Molecular glues that inhibit deubiquitylase activity and inflammatory signalling. [Preprint]